Abstracts Archive - Page 1601 of 2425 - ACR Meeting Abstracts

Abstract Number: 2760 • 2016 ACR/ARHP Annual Meeting
Assessment of Inflammatory Back Pain and Axial Spondyloarthritis in Brazil
Sonia Lima¹, Rita Menin², Rejane Vieira³, Antonio Ximenes⁴, Valderilio Azevedo⁵, Claudia Suzuki⁶ and Flavia Heringer⁶, ¹Faculdade de Medicina do ABC, São Paulo, Brazil, ²AV. JUSCELINO K. DE OLIVEIRA,, Famerp, Sao Jose Rio Preto, Brazil, ³Hospital Geral de Fortaleza, Fortaleza, Brazil, ⁴CIP- Centro Internacional de Pesquisa, Goiânia, Brazil, ⁵Federal University of Parana and Edumed Health Research Centerand Biotech, Curitiba, Brazil, ⁶AbbVie Farmacêutica Ltda., São Paulo, Brazil
Background/Purpose: This was an observational study with retrospective (phase 1) and one-month prospective (phase 2) data collection. Medical records of subjects 18-60 years old, with…
Abstract Number: 2761 • 2016 ACR/ARHP Annual Meeting
Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors
Ian Tin Yue Wong¹, Vinod Chandran², Suzanne Li³ and Dafna D Gladman⁴, ¹Faculty of Medicine, University of British Columbia, Vancouver,, BC, Canada, ²Medicine, Krembil Research Institute, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴University of Toronto, Toronto, ON, Canada
Background/Purpose: Psoriasis is a chronic inflammatory skin disease characterized by scaling, erythematous plaques. Up to 30% of psoriasis patients develop an inflammatory arthritis termed psoriatic…
Abstract Number: 2762 • 2016 ACR/ARHP Annual Meeting
Smoking and Severity of Psoriatic Arthritis
Sahithi Jarugula¹, Bonita Libman², Amanda Kennedy³ and Diantha Howard⁴, ¹Internal Medicine, Sahithi Jarugula, S.Burlington, VT, ²Internal Medicine, University of Vermont Medical Center, Burlington, VT, ³Internal Medicine, University of Vermont Medical center, Burlington, VT, ⁴Statistics, University of Vermont, Burlington, VT
Background/Purpose: Smoking is a major modifiable risk factor for various inflammatory diseases including rheumatoid arthritis 1, 2 and psoriasis 3,4,5. The presence of cyclic citrullinated…
Abstract Number: 2763 • 2016 ACR/ARHP Annual Meeting
New Treatment Option for SAPHO?
Jan Leipe¹, Dorothee Hauler², Johanna Meier¹, Matthias Witt¹, Mathias Grunke¹, Claudia Dechant³ and Hendrik Schulze-Koops¹, ¹Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany, ²Division of Rheumatology and Clinical Immunology, University of Munich, munich, Germany, ³Division of Rheumatology and Clinical Immunology, Med. Klinik und Poliklinik IV, University of Munich, Munich, Germany
Background/Purpose: The SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) is a rare autoimmune disease characterized by inflammatory osteoarticular and cutaneous manifestations. Despite improvements in…
Abstract Number: 2764 • 2016 ACR/ARHP Annual Meeting
Unhappiness Is Related to Worse Outcomes for Patients with Ankylosing Spondylitis and Increased Impairment in Daily Life Activities, Results from a Multinational Real-World Sample
Vibeke Strand¹, R Alten², Philip G. Conaghan³, Louise Huneault⁴, Emma Sullivan⁵, Stuart Blackburn⁵, Haijun Tian⁶, Kunal Gandhi⁶, Steffen Jugl⁷, Hedley Hamilton⁸ and Raj Mahapatra⁹, ¹Stanford University School of Medicine, Palo Alto, CA, ²Rheumazentrum Ruhrgebiet, Herne, Germany, ³NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, ⁴Novartis Pharma AG, Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland, ⁵Adelphi Real World, Manchester, United Kingdom, ⁶Novartis Pharmaceuticals Corporation, East Hanover, NJ, ⁷Novartis Pharma AG, Basel, Switzerland, ⁸any-3 Ltd, London, United Kingdom, ⁹gplus, London, United Kingdom
Unhappiness is Related to Worse Outcomes for Patients with Ankylosing Spondylitis and Increased Impairment in Daily Life Activities, Results from a Multinational Real-World Sample Background/Purpose:…
Abstract Number: 2765 • 2016 ACR/ARHP Annual Meeting
Practicing What We Preach? Do Psoriatic Arthritis Patients Treated at an Academic Medical Center Meet Caspar Criteria?
Sergio Schwartzman, Rima Abhyankar, Margaret Bogardus and Lisa Mandl, Hospital for Special Surgery, New York, NY
Background/Purpose: Psoriatic arthritis (PsA) is an autoimmune musculoskeletal disease with protean manifestations, and therefore can be difficult to diagnose. Although no diagnostic criteria are available, the…
Abstract Number: 2766 • 2016 ACR/ARHP Annual Meeting
The Predictive Value of Patient’s and Evaluator’s Global Assessment and Tender and Swollen Joint Count Differences on Treatment Efficacy in Psoriatic Arthritis: Data from a Longitudinal Multicenter Study
Brigitte Michelsen^1,2, Eirik K Kristianslund¹, Hilde B Hammer³, Karen M Fagerli¹, Elisabeth Lie¹, Glenn Haugeberg^4,5 and Tore K Kvien¹, ¹Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Dept. of Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, ³Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴Dept. of Rheumatology, Martina Hansens Hospital, Bærum, Norway, ⁵Dept. of Rheumatology, The Norwegian University of Science and Technology, Trondheim, Norway
Background/Purpose: Discordance between patient’s and physician’s evaluation of disease activity may be challenging in psoriatic arthritis (PsA). The potential impact of such a difference on…
Abstract Number: 2767 • 2016 ACR/ARHP Annual Meeting
Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: Evaluation of Modified Minimal Disease Activity upon Elimination of Each Component
Boulos Haraoui¹, Proton Rahman², Louis Bessette³, Philip Baer⁴, Suneil Kapur⁵, J. Antonio Avina-Zubieta⁶, Regan Arendse⁷, Emmanouil Rampakakis⁸, Eliofotisti Psaradellis⁹, Karina Maslova¹⁰, Allen J Lehman¹⁰, Francois Nantel¹¹, Brendan Osborne¹² and Cathy Tkaczyk¹², ¹University of Montreal, Montreal, QC, Canada, ²Rheumatology, St Claires Mercy Hospital, St Johns, NF, Canada, ³Rheumatology, CHUL de Quebec, Quebec, QC, Canada, ⁴Independent Rheumatology Practice, Scarborough, ON, Canada, ⁵University of Ottawa, 139 Greenbank Rd, Suite 203, ON, Canada, ⁶Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ⁷University of Saskatchewan, Saskatoon, SK, Canada, ⁸JSS Medical Research, St-Laurent, QC, Canada, ⁹JSS Medical Research, Montreal, QC, Canada, ¹⁰Janssen Inc., Toronto, ON, Canada, ¹¹19 Green belt Dr, Janssen Inc., Toronto, ON, Canada, ¹²Medical Affairs, Janssen Inc., Toronto, ON, Canada
Background/Purpose: Minimal disease activity (MDA) is now considered an attainable target in psoriatic arthritis (PsA) reflecting a desired state of comprehensive disease control. MDA is…
Abstract Number: 2768 • 2016 ACR/ARHP Annual Meeting
Prevalence of Obesity in Patients with Psoriatic Arthritis and Its Impact on the Severity of the Disease
Cecilia Zaffarana¹, Josefina Gallino Yanzi², Osvaldo Luis Cerda³, Margarita Landi⁴, Emilce Schneeberger¹ and Gustavo Citera¹, ¹Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ³IREP, CABA, Argentina, ⁴Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina
Background/Purpose: Epidemiological studies have found a high prevalence of obesity in patients with Psoriatic Arthritis (PsA). It was described the association between obesity and severity…
Abstract Number: 2769 • 2016 ACR/ARHP Annual Meeting
Does Gender Make a Difference in “Composite Psoriatic Disease Activity Index (CPDAI)” in Patients with Psoriatic Arthritis?
Gokce Kenar¹, Handan Yarkan², Berrin Zengin¹, Gerçek Can², Merih Birlik¹, Nurullah Akkoc¹ and Fatos Onen¹, ¹Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, ²Rheumatology, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey
Background/Purpose: “Composite psoriatic disease activity index (CPDAI)” includes 5 domains: peripheral joints, skin, enthesitis, dactylitis, and spinal manifestations in psoriatic arthritis (PsA) which is a…
Abstract Number: 2770 • 2016 ACR/ARHP Annual Meeting
Psoriatic Arthritis Limits Patients’ Abilities to Undertake Activities Crucial for Normal Daily Life and Impacts Happiness, Results from a Multinational Real-World Sample
Rieke Alten¹, Vibeke Strand², Philip G. Conaghan³, Louise Huneault⁴, Emma Sullivan⁵, Stuart Blackburn⁵, Haijun Tian⁶, Kunal Gandhi⁶ and Steffen Jugl⁷, ¹Schlosspark-Klinik, University Medicine, Berlin, Germany, ²Division of Immunology/Rheumatology, Stanford University, California, CA, ³NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, ⁴Novartis Pharma AG, Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland, ⁵Adelphi Real World, Manchester, United Kingdom, ⁶Novartis Pharmaceuticals Corporation, East Hanover, NJ, ⁷Novartis Pharma AG, Basel, Switzerland
Background/Purpose: This study investigated the impact of psoriatic arthritis (PsA) disease severity on patients’ (pts) ability to perform normal daily activities and their reported happiness.…
Abstract Number: 2771 • 2016 ACR/ARHP Annual Meeting
Higher Incident Rates of Comorbidities in Patients with Psoriatic Arthritis (PsA) Compared to Controls
Jeffrey Kaine¹, Xue Song², Gilwan Kim² and Jacqueline Palmer³, ¹Sarasota Arthritis Research Center, Sarasota, FL, ²Truven Health Analytics, Cambridge, MA, ³Novartis Pharmaceuticals Corporation, East Hanover, NJ
Background/Purpose: PsA is associated with higher rates of developing certain comorbidities, but little has been done to understand the incidence rates of comorbidities in…
Abstract Number: 2772 • 2016 ACR/ARHP Annual Meeting
Back Pain in Psoriatic Arthritis: Defining Prevalence, Characteristics and Performance of the Different Inflammatory Back Pain Criteria in a Psoriatic Arthritis Cohort
Kristy Yap¹, Suzanne Li¹, Dafna D Gladman² and Vinod Chandran³, ¹University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: Estimates of axial involvement in PsA vary from 25% to 70% depending on the inclusion criteria. Three sets of criteria are available for defining…
Abstract Number: 2773 • 2016 ACR/ARHP Annual Meeting
Assessment of the Static and Dynamic Balances in Psoriatic Arthritis (PsA) and Their Relations with Clinical, Radiological and Functional Parameters of Feet
M Tuncay Duruoz¹, Hatice Sule Baklacioglu², Canan Sanal Top³, Kardelen Gencer³ and Pamir Atagunduz⁴, ¹PMR Department, Rheumatology Division, Marmara University School of Medicine, Sisli-Istanbul, Turkey, ²PMR Department, Rheumatology Division, Marmara University School of Medicine, Istanbul, Turkey, ³PMR Department, Marmara University School of Medicine, Istanbul, Turkey, ⁴Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Background/Purpose: The feet are commonly affected in patients with psoriatic arthritis which cause impairment and disability. The purpose of the study is to assess the…
Abstract Number: 2774 • 2016 ACR/ARHP Annual Meeting
Framingham Risk Score Discriminates Coronary Atherosclerosis in Psoriatic Arthritis Patient Better Than Other Cardiovascular Scores Do
Ho Man LAM¹, Jiayun Shen², Qing SHANG³, Tsz Ho CHENG¹, Edmund LI¹, Ka Tat WONG⁴ and Lai-Shan TAM⁵, ¹Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ²Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, China, ³Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ⁴Prince of Wales Hospital, Hong Kong, Hong Kong, ⁵Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
Background/Purpose: Patients with psoriatic arthritis (PsA) are associated with higher cardiovascular (CV) risks. The efficacy of established CV risk scores for predicting CV risks in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].